STAT
JUNE 1, 2023
… Coherus BioSciences plans to sell a biosimilar version of Humira at a steep discount, STAT reports , and the company will work with Mark Cuban’s generic drug company to make the medicine available directly to consumers for even less. Neither vaccine is currently available for use.
Pharmaceutical Technology
SEPTEMBER 15, 2022
Last year was a positive year for biopharmaceutical companies, particularly those with Covid-19 vaccines. As a result of huge global sales of mRNA Covid-19 vaccines, the split in profits between Pfizer and BioNTech’s Comirnaty contributed towards revenues of $81.3bn and $22.4bn last year, respectively. YoY revenue growth.
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Big Molecule Watch
JUNE 25, 2024
As Big Molecule Watch continues to push past the bounds of biosimilars and into biologics, we are proud to announce the publication of two additional trackers concerning vaccines: the Vaccine Patent Litigation tracker and the Vaccine Patent PTAB tracker. The post Now Available!
Pharma in Brief
DECEMBER 3, 2020
Any authorization for drugs, vaccines, and medical devices issued pursuant to the interim orders are also set to terminate when the respective interim order expires or is withdrawn. Drugs and Vaccines. Both interim orders are set to expire 1 year after they were issued, or sooner if withdrawn by the Minister.
Pharmacy Times
JUNE 20, 2025
Expanding use of the 15-valent pneumococcal conjugate vaccine (PCV15) or 20-valent pneumococcal conjugate vaccine (PCV20) to all United States adults aged 50 to 64 years would result in modest budget increases over a 3-year period.
Pharmaceutical Business Review
APRIL 9, 2023
Located at the TÜBITAK MAM Gebze campus in Kocaeli province close to Istanbul, the MEDIBIYO facility can generate biotechnological drugs and vaccines that align with good manufacturing practice (GMP) standards, stated the Turkish publication. Ready to commence operation, this centre supports several industrial entities in the country.
Pharma Leaders
APRIL 9, 2023
Marmara Research Center (MAM) and The Scientific and Technological Research Council of Türkiye (TÜBITAK) have commenced Medical Biotechnology Research Center (MEDIBIYO) for the production of drugs and vaccines on a pilot scale, reported Daily Sabah. Ready to commence operation, this centre supports several industrial entities in the country.
Expert insights. Personalized for you.
246 
Let's personalize your content